159 related articles for article (PubMed ID: 28495148)
1. Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer.
Barrabés S; Llop E; Ferrer-Batallé M; Ramírez M; Aleixandre RN; Perry AS; de Llorens R; Peracaula R
Clin Chim Acta; 2017 Jul; 470():97-102. PubMed ID: 28495148
[TBL] [Abstract][Full Text] [Related]
2. Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.
Llop E; Ferrer-Batallé M; Barrabés S; Guerrero PE; Ramírez M; Saldova R; Rudd PM; Aleixandre RN; Comet J; de Llorens R; Peracaula R
Theranostics; 2016; 6(8):1190-204. PubMed ID: 27279911
[TBL] [Abstract][Full Text] [Related]
3. An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen.
Kammeijer GSM; Nouta J; de la Rosette JJMCH; de Reijke TM; Wuhrer M
Anal Chem; 2018 Apr; 90(7):4414-4421. PubMed ID: 29502397
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns.
Janković MM; Kosanović MM
Clin Biochem; 2005 Jan; 38(1):58-65. PubMed ID: 15607318
[TBL] [Abstract][Full Text] [Related]
5. Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer.
Fujita K; Hayashi T; Matsuzaki K; Nakata W; Masuda M; Kawashima A; Ujike T; Nagahara A; Tsuchiya M; Kobayashi Y; Nojima S; Uemura M; Morii E; Miyoshi E; Nonomura N
Oncotarget; 2016 Aug; 7(35):56643-56649. PubMed ID: 27494861
[TBL] [Abstract][Full Text] [Related]
6. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.
Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J
J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190
[TBL] [Abstract][Full Text] [Related]
7. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
[TBL] [Abstract][Full Text] [Related]
8. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract][Full Text] [Related]
9. A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia.
Dwek MV; Jenks A; Leathem AJ
Clin Chim Acta; 2010 Dec; 411(23-24):1935-9. PubMed ID: 20708609
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.
Hatano K; Yoneyama T; Hatakeyama S; Tomiyama E; Tsuchiya M; Nishimoto M; Yoshimura K; Miyoshi E; Uemura H; Ohyama C; Nonomura N; Fujita K
Br J Cancer; 2022 Mar; 126(5):764-770. PubMed ID: 34802050
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
[TBL] [Abstract][Full Text] [Related]
12. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
[No Abstract] [Full Text] [Related]
13. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428
[TBL] [Abstract][Full Text] [Related]
14. Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.
Ferrer-Batallé M; Llop E; Ramírez M; Aleixandre RN; Saez M; Comet J; de Llorens R; Peracaula R
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420168
[TBL] [Abstract][Full Text] [Related]
15. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the main PSA glycoforms in aggressive prostate cancer.
Gratacós-Mulleras A; Duran A; Asadi Shehni A; Ferrer-Batallé M; Ramírez M; Comet J; de Llorens R; Saldova R; Llop E; Peracaula R
Sci Rep; 2020 Nov; 10(1):18974. PubMed ID: 33149259
[TBL] [Abstract][Full Text] [Related]
17. Serum core-type fucosylated prostate-specific antigen index for the detection of high-risk prostate cancer.
Fujita K; Hatano K; Tomiyama E; Hayashi Y; Matsushita M; Tsuchiya M; Yoshikawa T; Date M; Miyoshi E; Nonomura N
Int J Cancer; 2021 Jun; 148(12):3111-3118. PubMed ID: 33594666
[TBL] [Abstract][Full Text] [Related]
18. Sialylation and fucosylation of cancer-associated prostate specific antigen.
Kosanović MM; Janković MM
J BUON; 2005; 10(2):247-50. PubMed ID: 17343337
[TBL] [Abstract][Full Text] [Related]
19. [Development and Clinical Application of Glycan-Targeted Biomarkers for Prostate Cancer].
Ohyama C; Yoneyama T; Tobisawa Y; Ishikawa T; Hatakeyama S; Koie T; Mori K
Rinsho Byori; 2017 Feb; 65(2):210-217. PubMed ID: 30762989
[TBL] [Abstract][Full Text] [Related]
20. Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer.
Vermassen T; Van Praet C; Vanderschaeghe D; Maenhout T; Lumen N; Callewaert N; Hoebeke P; Van Belle S; Rottey S; Delanghe J
Electrophoresis; 2014 Apr; 35(7):1017-24. PubMed ID: 24254641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
